SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-084453
Filing Date
2011-03-31
Accepted
2011-03-31 13:28:20
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1843329
2 LICENSE AGREEMENT - HE2000 dex1046.htm EX-10.46 102378
3 LICENSE AGREEMENT - APOPTONE (HE3235) dex1047.htm EX-10.47 101833
4 LICENSE AGREEMENT - TRIOLEX (HE3286) dex1048.htm EX-10.48 102193
5 CONSENT OF BDO USA, LLP dex231.htm EX-23.1 2780
6 CERTIFICATION OF JAMES M. FRINCKE dex311.htm EX-31.1 10439
7 CERTIFICATION OF ROBERT W. WEBER dex312.htm EX-31.2 10408
8 CERTIFICATIONS OF JAMES M. FRINCKE AND ROBERT W. WEBER dex321.htm EX-32.1 6412
  Complete submission text file 0001193125-11-084453.txt   2181015
Mailing Address 9171 TOWNE CENTRE DRIVE SUITE 180 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE SUITE 180 SAN DIEGO CA 92122 858-587-9333
Harbor BioSciences, Inc. (Filer) CIK: 0000899394 (see all company filings)

IRS No.: 133697002 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34584 | Film No.: 11725013
SIC: 2834 Pharmaceutical Preparations